APA (7th ed.) Citation

VA, P., & SV, O. (2026). Current Drug Development Pipeline for MASLD and MASH: Focusing on Cardiovascular Comorbidities. Biomedicines, 14(4), . https://doi.org/10.3390/biomedicines14040909

Chicago Style (17th ed.) Citation

VA, Prikhodko, and Okovityi SV. "Current Drug Development Pipeline for MASLD and MASH: Focusing on Cardiovascular Comorbidities." Biomedicines 14, no. 4 (2026). https://doi.org/10.3390/biomedicines14040909.

MLA (9th ed.) Citation

VA, Prikhodko, and Okovityi SV. "Current Drug Development Pipeline for MASLD and MASH: Focusing on Cardiovascular Comorbidities." Biomedicines, vol. 14, no. 4, 2026, https://doi.org/10.3390/biomedicines14040909.